Bacterial pneumonia future or investigational therapies
|
Bacterial pneumonia Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Bacterial pneumonia future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Bacterial pneumonia future or investigational therapies |
|
FDA on Bacterial pneumonia future or investigational therapies |
|
CDC onBacterial pneumonia future or investigational therapies |
|
Bacterial pneumonia future or investigational therapies in the news |
|
Blogs on Bacterial pneumonia future or investigational therapies |
|
Risk calculators and risk factors for Bacterial pneumonia future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz
Overview
Due to increasing antibiotic resistance and emerging organisms, it is important that the approaches to diagnosing pneumonia continue to be developed. Currently, the host factors predisposing one to pneumonia are being studied in detail.[1] These include:
- Host susceptibility including age, genetic factors, exposures (such as cigarette smoke), chronic diseases and acute conditions allowing pneumonia to develop
- Host response to infection including immune resistance, vaccination response, and repair mechanisms
- Host consequences such as the development of complications and exacerbation of existing chronic conditions
References
- ↑ Dela Cruz CS, Wunderink RG, Christiani DC, Cormier SA, Crothers K, Doerschuk CM; et al. (2018). "Future Research Directions in Pneumonia. NHLBI Working Group Report". Am J Respir Crit Care Med. 198 (2): 256–263. doi:10.1164/rccm.201801-0139WS. PMC 6058989. PMID 29546996.